Britain’s new National Wealth Fund has struck a £1bn deal with two of Britain’s biggest high street lenders to retrofit thousands of homes to upgrade their energy-efficiency. Sky News has learnt that the government-backed vehicle has agreed with Barclays and Lloyds Banking Group to provide partial guarantees on loans to housing associations across Britain. An
0 Comments
The OpenAI app icon displayed along with other AI applications on a smartphone. Jonathan Raa | Nurphoto via Getty Images Technology giants are turning to nuclear energy to power the energy-intensive data centers needed to train and run the massive artificial intelligence models behind today’s generative AI applications. Microsoft and Google are among the firms
0 Comments
Thomas Tuchel, the former Chelsea and Bayern Munich coach, has signed a deal to become the new England manager. The German, who has been out of work since leaving Bayern in the summer, will become the full-time successor to Gareth Southgate, who resigned after England’s defeat to Spain in the final of Euro 2024 in
0 Comments
On October 13, 2024, SpaceX launched its Starship vehicle from South Texas. This mission is particularly notable for successfully capturing its Super Heavy booster at the launch site, marking a significant achievement in aerospace technology. The successful launch and recovery illustrate SpaceX’s commitment to advancing reusable rocket technology, which is vital for reducing costs and
0 Comments
Energica, Europe’s leading electric motorcycle maker and often considered ‘the Ducati of e-motorcycles’, appears to be in financial distress. New reports from local media indicate that the Italian motorcycle maker may be headed for collapse. According to the Italian newspaper Chronica, Energica’s employees are preparing to strike in response to financial uncertainty regarding their employment
0 Comments
In recent years, injectable medications like Ozempic, Wegovy, and Mounjaro have emerged as powerful tools for weight loss and managing blood sugar levels. These drugs, which act as GLP-1 receptor agonists, have garnered significant attention, leading to soaring sales and becoming billion-dollar products. However, their high costs, typically ranging from £800 to £1,000 per month,
0 Comments